Economic Update 8-17-2020
- Economic data for the week included further gains in retail sales, and industrial production, among other measures. Consumer sentiment and jobs results also showed improvement, all of which look to a stronger showing for the third quarter over the second.
- Global equities experienced gains last week as investors look ahead to economic growth beyond Covid, especially as prospects for a vaccine improve (and Russia approving a vaccine). Bonds fell back, however, as interest rates crept up along with this same news. Commodities gained, with price increases for agriculture and natural gas, and less so for crude oil, which has been more stable as of late.
U.S. stocks gained last week, with the S&P again nearing prior highs from February. This movement appeared to coincide with stronger economic results, including reports about dramatic improvements in air travel numbers, as well as continued optimism over progress towards a Covid vaccine. This seemed to offset continued uncertainty over legislative action towards further fiscal stimulus, as well as Chinese retail sales data that fell short of expectations that assumed continual recovery. By sector, cyclical groups industrials and energy led with gains of several percent, while defensive utilities lagged with declines of an equivalent amount.
Foreign stocks experienced stronger gains than domestic, led by Japan, and more tempered results for emerging markets. The positivity in equity results echoed that in the U.S., despite rising virus numbers in several European locations and enhanced travel restrictions. Chinese retail sales fell far short of expectations for July, bucking improvement elsewhere, so served as a disappointment to global investors looking to the nation as a ‘template’ for a V-shaped pandemic recovery. Reports of an approved Russian Covid vaccine helped sentiment in that region.
U.S. bonds fell last week as interest rates ticked higher along the longer end of the yield curve, with economic data showing improvement. Such a speeding up of expectations for stronger economic growth sooner also raise the probabilities of interest rates moving up sooner as well (although ‘soon’ in this case is certainly relative). U.S. government bonds fared slightly better than corporates, as both investment-grade and high yields spreads widened, while bank loans showed positive results in keeping with the higher rates. Foreign bonds were similarly flat to down on net.
Commodities gained a bit across the board, led by agriculture and energy, while precious metals fell back by nearly -4%. The price of crude oil rose by about 2% to around $42/barrel, continuing in a recent trading range, as inventories fell a bit—tempered by continued weak demand. Natural gas prices gained over 5%.
Period ending 8/14/2020 | 1 Week (%) | YTD (%) |
DJIA | 1.87 | -0.68 |
S&P 500 | 0.69 | 5.66 |
Russell 2000 | 0.59 | -4.62 |
MSCI-EAFE | 2.46 | -5.23 |
MSCI-EM | 0.35 | -1.93 |
BBgBarc U.S. Aggregate | -0.91 | 6.85 |
U.S. Treasury Yields | 3 Mo. | 2 Yr. | 5 Yr. | 10 Yr. | 30 Yr. |
12/31/2019 | 1.55 | 1.58 | 1.69 | 1.92 | 2.39 |
8/7/2020 | 0.10 | 0.13 | 0.23 | 0.57 | 1.23 |
8/14/2020 | 0.10 | 0.14 | 0.29 | 0.71 | 1.45 |
Sources: LSA Portfolio Analytics, American Association for Individual Investors (AAII), Associated Press, Barclays Capital, Bloomberg, Deutsche Bank, FactSet, Financial Times, Goldman Sachs, JPMorgan Asset Management, Kiplinger’s, Marketfield Asset Management, Minyanville, Morgan Stanley, MSCI, Morningstar, Northern Trust, Oppenheimer Funds, Payden & Rygel, PIMCO, Rafferty Capital Markets, LLC, Schroder’s, Standard & Poor’s, The Conference Board, Thomson Reuters, U.S. Bureau of Economic Analysis, U.S. Federal Reserve, Wells Capital Management, Yahoo!, Zacks Investment Research. Index performance is shown as total return, which includes dividends, with the exception of MSCI-EM, which is quoted as price return/excluding dividends. Performance for the MSCI-EAFE and MSCI-EM indexes is quoted in U.S. Dollar investor terms.
The information above has been obtained from sources considered reliable, but no representation is made as to its completeness, accuracy or timeliness. All information and opinions expressed are subject to change without notice. Information provided in this report is not intended to be, and should not be construed as, investment, legal or tax advice; and does not constitute an offer, or a solicitation of any offer, to buy or sell any security, investment or other product.
FOR ADVISOR USE ONLY – NOT FOR DISTRIBUTION TO THE PUBLIC WITHOUT PRIOR APPROVAL FROM YOUR RESPECTIVE FIRM’S COMPLIANCE DEPARTMENT